Skip to content

Clinical trials

Observational Parkinson Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Observational Country / region: Canada Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20092
20111
20133
20142
20153
20166
20171
20182
20193
20203
20214
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting7
Active, not recruiting5
Unknown status4
Enrolling by invitation3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
University Health Network, Toronto3
BlueRock Therapeutics2
Indiana University2
McGill University2
Michael J. Fox Foundation for Parkinson's Research2
Pacific Parkinson's Research Centre2
University of Saskatchewan2
Washington University School of Medicine2
Assistive Technology Clinic, Canada1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease40
Alzheimer Disease5
Lewy Body Disease5
Cognitive Dysfunction4
Frontotemporal Dementia3
Movement Disorders3
Multiple System Atrophy3
REM Sleep Behavior Disorder3
Dementia2
Essential Tremor2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.